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Rag	enzymes	are	the	main	players	in	V(D)J	recombination,	the	process	responsible	for	rearrangement	of	TCR	
and	Ig	genes.	Hypomorphic	Rag	mutations	in	humans,	which	maintain	partial	V(D)J	activity,	cause	a	peculiar	
SCID	associated	with	autoimmune-like	manifestations,	Omenn	syndrome	(OS).	Although	a	deficient	ability	
to	sustain	thymopoiesis	and	to	produce	a	diverse	T	and	B	cell	repertoire	explains	the	increased	susceptibility	to	
severe	infections,	the	molecular	and	cellular	mechanisms	underlying	the	spectrum	of	clinical	and	immunologi-
cal	features	of	OS	remain	poorly	defined.	In	order	to	better	define	the	molecular	and	cellular	pathophysiology	
of	OS,	we	generated	a	knockin	murine	model	carrying	the	Rag2	R229Q	mutation	previously	described	in	sever-
al	patients	with	OS	and	leaky	forms	of	SCID.	These	Rag2R229Q/R229Q	mice	showed	oligoclonal	T	cells,	absence	of	
circulating	B	cells,	and	peripheral	eosinophilia.	In	addition,	activated	T	cells	infiltrated	gut	and	skin,	causing	
diarrhea,	alopecia,	and,	in	some	cases,	severe	erythrodermia.	These	findings	were	associated	with	reduced	thy-
mic	expression	of	Aire	and	markedly	reduced	numbers	of	naturally	occurring	Tregs	and	NKT	lymphocytes.	In	
conclusion,	Rag2R229Q/R229Q	mice	mimicked	most	symptoms	of	human	OS;	our	findings	support	the	notion	that	
impaired	immune	tolerance	and	defective	immune	regulation	are	involved	in	the	pathophysiology	of	OS.
Introduction
Omenn syndrome (OS) is a peculiar immunodeficiency in which 
a defect in immune response against pathogens coexists with 
signs of autoimmunity (1, 2). Clinically described for the first 
time in 1965 (3), OS has been characterized at the clinical level 
as a SCID with erythrodermia, hepatosplenomegaly, failure to 
thrive, susceptibility to infections, diarrhea, and a fatal outcome, 
unless treated with bone marrow transplantation (3–6). At the 
laboratory level, patients manifest eosinophilia and elevated IgE 
despite the absence of B cells, while T cell numbers are often nor-
mal or elevated. Although these T cells are oligoclonal, show a 
limited TCR repertoire, and express activation markers, they are 
not functional, thus justifying the combined nature of the immu-
nodeficiency (7, 8). Mutations in either Rag1 or Rag2 are found in 
most, but not all, OS patients. Interestingly, these mutated pro-
teins seem to maintain partial activity, as they are able to direct 
some recombination events that give rise to oligoclonal T cell 
populations, which could be responsible for peculiar manifesta-
tions of OS. Indeed, OS patients show an autoimmune phenotype 
that is not present in SCID patients carrying null Rag mutations 
(9). Although the presence of partial recombination activity is a 
prerequisite for OS due to Rag defects, it is likely that environ-
mental factors such as exposure to specific pathogens could trig-
ger the autoimmune response, since coexistence of SCID and 
OS in the same family has been described previously (10, 11). 
In particular, patients with typical OS-type Rag mutations who 
received bone marrow transplants very early did not manifest OS 
features, while their siblings who were diagnosed later did. More 
recently, other genes involved in OS have been described (12, 13), 
including a very rare Artemis mutation (14); this finding is also 
compatible with the same pathogenesis, since residual Artemis 
activity could allow a limited number of recombination events. 
Although the demonstration that the basic biochemical defect 
of OS lies in the process of recombination, this finding leaves 
several open questions. In particular, it is unclear whether selec-
tion of gene segments in V-to-J recombination is skewed in OS 
and whether V regions are selected for rearrangement based on 
their locations along the chromosome or on perfect matching of 
their recombination signal sequences. Furthermore, it is unknown 
whether secondary V(D)J rearrangements occur in OS. In addi-
tion, the mechanisms accounting for target tissue infiltration 
by activated lymphocytes are also largely unknown. Specifically, 
it is unclear whether defects in negative selection in the thymus 
or in generation and/or function of Tregs may play a role in the 
pathophysiology of peripheral tissue damage. Finally, the origin 
of elevated serum IgE remains to be defined, considering that IgE 
production requires normal V(D)J recombination and class switch, 
while few B cells are usually detected in OS patients.
Addressing these and other similar questions is challenging in 
humans, in which collection of samples is limited for ethical rea-
sons. The availability of an animal model recapitulating the patho-
genesis of OS would be important for understanding the cellular 
mechanism of this disease and might also provide useful insights 
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into the pathophysiology of autoimmunity in general. Therefore, 
through recombination in ES cells, we generated a knockin mouse 
bearing a mutation in the Rag2 gene, which has previously been 
shown to be associated with OS in several patients (10, 11, 15). This 
mouse showed a heritable phenotype very close to that of human 
OS, including development of oligoclonal and activated T cells that 
infiltrate target tissues causing gut and skin abnormalities.
Results
Generation of the Rag2R229Q/R229Q model. A targeting construct bear-
ing a Rag2/enhanced GFP (Rag2/EGFP) fused gene carrying the 
R229Q mutation and a novel NheI site was engineered to use 
for homologous recombination in ES cells (see Figure 1A and 
Methods). EGFP was introduced as gene reporter to follow the 
proper expression of Rag2 during T and B cell differentiation. 
This construct included about 3 kb of homology both upstream 
and downstream of the coding region containing the introduced 
mutation, and a neomycin resistance gene (PGK-neor) flanked 
by loxP sites was cloned downstream of the untranslated region 
(UTR) in the 3′ homology region.
Targeted replacement of Rag2 with the Rag2-R229Q/GFP vec-
tor was performed in 129Sv ES cells. PCR and Southern blot 
screening revealed that 1 ES cell clone underwent the expected 
homologous recombination event (Figure 1B). Chimeric mice 
derived from ES cell clones were crossed with wild-type mice, and 
the heterozygous progeny was crossed with CMV-Cre–expressing 
mice in order to eliminate the neo cassette and thus obtain the 
founder knockin Rag2+/R229QneoΔ mice. We confirmed the excision 
of neo by Southern blot analysis (Figure 1B). These mice were 
crossed to produce the homozygous Rag2R229Q/R229Q mice used in 
this study, which were screened by direct sequencing (Figure 1C). 
Heterozygous mice did not show any immunological defects or 
growth impairment (data not shown).
Analysis of the progeny obtained after breeding heterozygous 
Rag2+/R229Q mice showed that Rag2+/R229Q and Rag2R229Q/R229Q mice 
were viable and generated according to Mendelian inheritance. 
Homozygous Rag2R229Q/R229Q mice were fertile and were used to 
produce further generations, with an equal representation of male 
and female progeny.
Phenotypic analysis of Rag2R229Q/R229Q mice showed normal appear-
ance at birth. However, at 8–10 weeks of age, 60% of the homozygous 
mutant mice developed substantial dorsal and facial hair loss. In 
addition, after an initial period of normal growth, a minority (4% of 
all Rag2R229Q/R229Q mice) started to develop severe alopecia, skin eryth-
rodermia, and wasting syndrome due to colitis (Figure 2A).
Histological analysis of Rag2R229Q/R229Q mice revealed marked 
infiltration by T lymphocytes and eosinophils in the skin and 
gut (Figure 2, B and C) that contrasted with the overall lymphoid 
depletion observed in the thymus, lymph nodes, and spleen. Simi-
lar to what we observed in Rag2–/– mice, immunostaining for cyto-
keratin 5, which detects medullary epithelium, revealed a diffuse 
network throughout thymic parenchyma with loss of corticome-
dullary differentiation in the thymi of Rag2R229Q/R229Q mice (Fig-
ure 2, D and E). Furthermore, unlike the thymic medullary region 
in Rag2+/+ mice, the thymi in Rag2R229Q/R229Q mice were defective 
in forming Hassall corpuscle–like clusters (data not shown) (16). 
Abnormal architecture was also observed in lymph nodes, which 
revealed severe B cell depletion as well as a lack of B follicles (Figure 
2F) and were composed of a diffuse population of pale histiocytes 
and dendritic cells admixed with T cells and eosinophils (Figure 
2G). Moreover, scattered activated CD3+ and CD30+ immuno-
blasts were found in these areas (Figure 2G, right panels). Spleens 
from Rag2R229Q/R229Q mice showed similar morphological altera-
tions, with severe depletion of the white pulp and particularly of 
B cells (data not shown). No Peyer patches were recognized in the 
gut. These pathological changes were consistently detected in all 
Rag2R229Q/R229Q mice at 6–8 weeks of age, regardless of the sever-
ity of clinical manifestations; however, the T cell infiltration and 
peripheral eosinophilia were more severe in mice that developed 
erythrodermia and wasting syndrome.
Figure 1
Generation of Rag2R229Q/R229Q ES cells and mice. (A) 
A targeting vector was designed to replace endog-
enous Rag2 with the gene carrying the R229Q sub-
stitution and an NheI restriction site. GFP was fused 
in frame with the Rag2 neo cassette flanked by loxP 
sites (arrows), which was cloned downstream of the 
Rag2 UTR (black box). Gray boxes denote the 3′ 
probe used for genomic screening. (B) Southern 
blot analysis using the 3′ probe on EcoRV-digested 
genomic DNAs. Lane 1, 129Sv wild-type ES cells; 
lane 2, Rag2+/R229QneoΔ recombinant ES cells; lane 3, 
heterozygous Rag2+/R229QneoΔ mouse after neo excision 
due to Cre cross; lane 4, 129Sv Rag2+/+ mouse; lane 5, 
Rag2+/R229QneoΔ mouse. (C) Chromatogram showing 
nucleotide substitutions, denoted by underline: the first 
2 changes obtained the NheI restriction site, the last 2 
caused the R to Q amino acid change (bold).
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T cell differentiation in Rag2R229Q/R229Q mice. Analysis of Rag2-
R229Q/GFP expression in thymocyte subsets revealed develop-
mental regulation characteristic of Rag2 (17, 18) (Supplemental 
Figure 1; supplemental material available online with this article; 
doi:10.1172/JCI30928DS1).
Cell recovery from Rag2R229Q/R229Q thymi was analogous to that of 
Rag2–/– thymi and markedly reduced compared with that of Rag2+/+ 
thymi (Supplemental Figure 2). Staining with CD4 and CD8 anti-
bodies revealed a dramatic depletion of the CD4+CD8+ double-posi-
tive (DP) compartment, with relative enrichment of the CD4–CD8– 
double-negative (DN) subset, the predominant subset (Figure 3A).
Developmental progression of DN cells is characterized by an 
ordered sequence of phenotypes defined by CD44 and CD25 
expression: CD44+CD25– (DN1) to CD44+CD25+ (DN2), CD44–
CD25+ (DN3), and CD44–CD25– (DN4). The DN3 to DN4 tran-
sition is predominantly controlled by productive rearrangement 
of the TCR-β locus and expression of the pre-TCR in the plasma 
membrane. Analysis of DN cells from Rag2R229Q/R229Q thymi with 
CD25 and CD44 antibodies revealed an almost complete arrest of 
thymocyte development at the DN3 stage, a hallmark of recom-
binase-deficient mice (Figure 3, A and B) (19). Nevertheless, a few 
DP cells were recovered and displayed progressive upregulation 
of TCR-α/β with concomitant expression of CD69, a feature of 
ongoing positive selection. CD4+ as well as CD8+ single-posi-
tive (SP) cells expressed high levels of TCR-α/β, which suggests 
that minute amounts of thymocytes were positively selected and 
accumulated as SP cells (Figure 3A). Moreover, γδ T cells were not 
detected (data not shown).
Next, we examined the T cell compartment in secondary lym-
phoid organs. The spleen and the mesenteric, inguinal, and cervi-
cal lymph nodes were severely reduced in size and dysmorphic, the 
absolute numbers of CD4 and CD8 lymphocytes and percentage 
of NKT cells were dramatically reduced (Supplemental Figure 2), 
and γδ T cells were absent. Flow cytometry analysis of lymph 
nodes showed a distribution of CD4+ and CD8+ T cells analogous 
to that of Rag2+/+ animals (Figure 4A); however, the vast majority 
(~80%) of cells in both subsets displayed an effector/memory-like 
CD44+CD62Llow phenotype (Figure 4A). Similar observations were 
made in the spleen (data not shown).
To assess the functional activity of peripheral T cells in 
Rag2R229Q/R229Q mice, CD90+ cells were positively selected from 
total splenocytes and stimulated in vitro with increasing doses of 
anti-CD3 mAb. Proliferative responses were absent or markedly 
decreased in Rag2R229Q/R229Q mice, and neither costimulation with 
Figure 2
Histological analysis of Rag2R229Q/R229Q mice. (A) Phenotypic aspect 
of a 3-month-old Rag2R229Q/R229Q mouse, showing severe alopecia 
and skin erythrodermia. (B) Skin biopsy revealed marked dermal 
inflammation (top) composed of CD3+ lymphocytes (bottom left) and 
containing numerous eosinophils (bottom right). Original magnifica-
tion, ×10 (top); ×20 (bottom). (C) Similarly, the gut showed dense 
inflammatory infiltration (left), mainly composed of CD3+ cells (right). 
Original magnification, ×20. (D and E) Comparison between thymic 
tissue from age-matched 6-week-old Rag2+/+ and Rag2R229Q/R229Q 
mice: the normal corticomedullary differentiation observed in Rag2+/+ 
thymus (D), as highlighted by the anti–cytokeratin 5 immunostaining 
(D, inset), was absent in the Rag2R229Q/R229Q mouse (E and inset). 
Original magnification, ×4 (D and E). (F) B220 immunostaining 
showed B follicles (b) and paracortical areas (p) in Rag2+/+ mice 
(left) in contrast to the abnormal architecture and severe depletion of 
B cells observed in Rag2R229Q/R229Q mice (right). Original magnifica-
tion, ×4. (G) Nodal parenchyma from the Rag2R229Q/R229Q (left) shows 
admixture of histiocytes, large activated lymphoid cells (arrow), and 
eosinophils (arrowhead); most lymphoid cells were CD3+ lympho-
cytes (top right) that expressed the activation antigen CD30 (bottom 
right). Original magnification, ×20 (left); ×40 (right).
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CD28 (data not shown) or addition of IL-2 to the medium res-
cued T cell proliferation (Figure 4B). However, T cells stimulated 
with phorbol 12-myristate 13-acetate/iomomycin (PMA/iomomy-
cin) showed increased intracellular production of IL-2, IFN-γ, and 
TNF-α in both CD4 and CD8 subsets (Supplemental Figure 3).
We analyzed T cell repertoire by investigating TCRVβ use among 
thymocytes and splenocytes obtained from 2 and 4 Rag2R229Q/R229Q 
mice, respectively, and the results were compared with those in 
Rag2+/+ mice. Figure 5A shows that in Rag2R229Q/R229Q mice, use of 
some TCRVβ family members increased in frequency within total T 
cells compared with that of Rag2+/+ mice, both in the thymus and in 
the spleen. Interestingly, while use of some TCRVβ family members, 
such as TCRVβ3, expanded both in the spleen and in the thymus, 
other members showed a different distribution in the 2 organs. The 
immunoscope profiles in Figure 5B demonstrate the diversity of 
the TCR by showing the distribution of TCR third complementa-
rity-determining region (CDR3) length for each TCRVβ-TCRCβ 
rearrangement. While the Rag2+/+ mice showed a typical polyclonal 
distribution of CDR3 length, Rag2R229Q/R229Q mice presented oligo-
clonal patterns for most of the TCRVβ family members.
B cell differentiation in Rag2R229Q/R229Q mice. Most patients with OS 
show absence or severely reduced numbers of circulating B cells 
and profound hypogammaglobulinemia in spite of high levels of 
IgE. In Rag2R229Q/R229Q mice, the number of B220+ cells was severely 
reduced in both bone marrow and spleen (Figure 6, A and B), sug-
gesting that B cell development was impaired. In the bone mar-
row, productive rearrangement of the IgM heavy chain locus and 
expression of the membrane-bound pre–B cell receptor determines 
the developmental transition of B cell progenitors from the pro–B 
cell stage to the pre–B cell stage. We analyzed pro–B cell to pre–B 
cell transition by staining bone marrow cells with B220 and CD2 
antibodies. As shown in Figure 6A, we observed a complete absence 
of B220lowCD2+ pre–B cells and B220highCD2+ cells that comprised 
immature and mature recirculating B cells, as was observed in 
Rag2–/– mice (20). Transitional B cells migrate to the spleen through 
the bloodstream and start to express membrane-bound IgD. IgM 
and IgD staining can distinguish transitional and mature recir-
culating B cells. In the bone marrow of Rag2R229Q/R229Q mice, both 
these cell subsets were undetectable (Figure 6A). In the spleens of 
Rag2R229Q/R229Q mice, few mature follicular IgM+IgD+ B cells were 
detected, and transitional B cells were undetectable. Further stain-
ing of splenocytes for the complement receptor CD21 and the low-
affinity receptor for IgE, CD23, revealed few CD21+CD23+ mature 
follicular B cells and a lack of CD21+CD23– marginal zone B cells 
(21), showing that B cell development was severely compromised 
in Rag2R229Q/R229Q mice (Figure 6B).
Along with the severe defect in B cell differentiation, Rag2R229Q/R229Q 
mice showed hypogammaglobulinemia, with reduced levels of 
all IgG subclasses as well as of IgA and IgM. Although mean IgE 
serum levels were comparable to those of wild-type mice, some 
Rag2R229Q/R229Q mice had markedly increased IgE (Figure 7), which 
correlated with more pronounced phenotypic manifestations. 
Despite the presence of low but detectable Ig levels, Rag2R229Q/R229Q 
mice challenged with OVA were unable to produce OVA-specific 
antibodies (data not shown).
Central and peripheral tolerance in Rag2R229Q/R229Q mice. The appro-
priate development of the thymic epithelial component is particu-
larly relevant for T cell homeostasis because medullary epithelium 
expresses tissue-specific self antigens under the control of the 
transcription factor autoimmune regulator (AIRE). Rag2R229Q/R229Q 
mice displayed atrophic thymi, which were macroscopically indis-
tinguishable from those of Rag–/– mice, and did not reveal a medul-
lary compartment in histochemical study. Analysis of Aire expres-
sion in Rag2R229Q/R229Q thymi revealed low levels of Aire mRNA, as 
Figure 3
Impaired T cell development and aberrant 
peripheral T cell activation in Rag2R229Q/R229Q 
mice. (A) Top left: Fluorescence-activated 
cell sorting analysis of thymocytes from the 
indicated mice stained with CD4 and CD8 
antibodies. Top right: CD4–CD8– cells were 
gated and analyzed for CD44 and CD25 
expression. Bottom left: TCR-β and CD69 
expression in electronically gated CD4+8+ 
cells. The percentage of TCR-βbrightCD69+ 
cells is indicated. Bottom right: Overlay of 
TCR-β surface expression in the indicat-
ed thymocyte subsets (gray histograms, 
Rag2+/+; open histograms, Rag2R229Q/R229Q). 
(B) Left: Percentage of cells during different 
T cell differentiation stages in the thymus. 
Right: Percentage of differentiating DN cells. 
Results are the mean and SD of 5 Rag2+/+ 
and 10 Rag2R229Q/R229Q mice. P values were 
determined by unpaired Student’s t test.
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observed in Rag2–/– mice, which are devoid of the medullary com-
ponent of the organ (Figure 8A). In keeping with a possible defect 
in central tolerance related to reduced Aire expression, abnormal 
and severe lymphocyte infiltration in lungs and livers was observed 
in Rag2R229Q/R229Q mice (Figure 8, B–E). Finally, we evaluated the 
presence of naturally occurring Tregs (nTregs; defined here as 
CD25highFoxp3+) in our murine model. This subset has been shown 
to be crucial to prevent autoimmune manifestations (22). In order 
to determine whether nTregs could be reduced in Rag2R229Q/R229Q 
mice, Foxp3 expression was analyzed in thymus, spleen, and 
Figure 4
Peripheral T cells and T cell proliferation. (A) Top: Fluorescence-activated cell sorting analysis of lymph node cells stained with CD4 and CD8 
antibodies. Bottom: CD4+ and CD8+ cells from the indicated mice were analyzed for CD44 and CD62L distribution. (B) Proliferation of Rag2+/+ and 
Rag2R229Q/R229Q CD90+ cells isolated from splenocytes, plated at 2 × 105 cells per well, and stimulated as indicated. Proliferation was assessed by 
3H-thymidine incorporation in triplicate wells. Plotted values are cpm for each individual mouse. Bars represent the median for each group.
Figure 5
Immunoscope analysis of TCR repertoire. (A) Quantitative TCRVβ repertoire determined by real-time PCR analysis on T cells from the 2 thymi 
and 4 spleens from Rag2R229Q/R229Q mice (designated as 1–4) and from 2 representative Rag2+/+ mice (designated as 1 and 2). (B) Represen-
tative immunoscope profiles of TCRVβ analysis in the thymi and spleens of the mice as in A. The x axes represent CDR3 length, and y axes 
represent arbitrary fluorescence intensity of the runoff products. 
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lymph nodes. The number of nTregs in all tissues examined was 
significantly decreased in Rag2R229Q/R229Q mice compared with 
Rag2+/+ mice (Figure 9).
Discussion
Hypomorphic mutations in Rag1 and Rag2 genes in humans have 
been associated with a spectrum of clinical and immunological 
manifestations that range from typical and severe T–B– SCID to 
leaky SCID (with residual production of T cells and occasion-
ally B cells) to OS, a disorder characterized by the presence of 
autologous, activated T cells that infiltrate target organs (3). The 
reasons underlying this variable phenotype are unclear. Along 
with the primary genetic defect, both genetic background and 
environmental factors have been postulated to play a role in the 
pathophysiology of the disease (23, 24). In addition, defective thy-
mopoiesis has been shown to impair Aire expression in the thymic 
medulla, thus disturbing negative selection of autoreactive T cells 
that may escape to the periphery and damage target organs (25). 
In agreement with these observations, a variety of genetic defects 
that affect early T cell development have been recently shown to 
cause OS in humans (12–14). In order to develop a model that 
recapitulates OS and could therefore be used to better dissect 
the mechanisms behind the various phenotypic manifestations 
of the disease, we have developed a homozygous Rag2 knockin 
mouse carrying the R229Q mutation. We chose to investigate the 
effects of this mutation, as it was originally described in a patient 
with leaky SCID (15), and we and others subsequently found this 
amino acid change in several patients with OS and in infants with 
leaky SCID (10, 11). In this regard, the R229Q mutation offers 
a unique setting in which to evaluate the contributory roles of 
genetic background and environmental factors in determining 
the phenotype. Biochemical investigation of this mutant form of 
Rag2 has previously been shown to reduce V(D)J recombination 
activity by over 150-fold (10, 15).
We found that introduction of the Rag2 R229Q mutation did 
not affect viability and fertility in mice, but severely impaired 
T and B cell development and recapitulated most of the leaky fea-
tures of OS. In particular, thymocyte development was predomi-
nantly arrested at the DN3 stage, during which expression of RAG 
is required to proceed along the differentiation pathway.
The few SP thymocytes generated in Rag2R229Q/R229Q mice expressed 
TCR-α/β at the cell surface and were exported to the periphery, 
where they infiltrated target organs. Interestingly, the pattern of 
T cell infiltration observed in Rag2R229Q/R229Q mice mimicked that 
observed in patients with OS, with preferential localization in the 
skin and in the gut. Furthermore, the infiltrating T lymphocytes 
express activation markers and are oligoclonal, suggesting selective 
peripheral expansion (8). Competition within an appropriate num-
ber of clonal specificities upon microbial infection could ensure 
self tolerance; thus the reduced diversity of the T cell repertoire in 
Rag2R229Q/R229Q mice could favor the expansion of T cell clones with 
inappropriate reactivity toward self-peptide/MHC complexes and 
development of immunopathology. In addition, because compen-
satory peripheral T cell expansion in lymphopenia was previously 
shown to produce autoimmune disease (26), the reduced thymic 
output in Rag2R229Q/R229Q mice could predispose animals to auto-
immunity. A defective expression of tissue-specific self antigens 
controlled by AIRE contributes to the pathogenesis of autoim-
mune manifestations (27, 28). Rag2R229Q/R229Q mice have atrophic 
thymi and barely detectable Aire expression, suggesting a defect in 
negative selection of potentially self-reactive T cells (25, 29). The 
defective Aire expression might lead to the severe lymphocyte infil-
tration in target organs observed in the livers, lungs, and skin of 
affected mice. In Rag2R229Q/R229Q mice, few DP cells were detected 
and TCR-β chains were undetectable by intracellular staining in 
DN cells (data not shown), implying severe impairment of pre-TCR 
expression and signaling. Because signaling by the pre-TCR could 
influence thymic epithelium development (30), we speculate that 
Figure 6
Impaired B cell development in Rag2R229Q/R229Q mice. 
(A) Top: Relative representation and SD of B220low and 
B220high cells in the bone marrow of the indicated mice 
(n = 6). Bottom: Dot-plot analysis of bone marrow cells 
from the indicated mice labeled with B220 and CD2 
antibodies and IgD and IgM expression of electronically 
gated B220+ bone marrow cells. (B) Top: Relative rep-
resentation and SD of B220+ cells in the spleens of the 
indicated mice (n = 6). Bottom: Dot-plot analysis of B220+ 
splenocytes labeled with CD21 and CD23 antibodies or 
IgD and IgM antibodies. P values were determined by 
unpaired Student’s t test. Numbers indicate the percent-
age of cells in the indicated gates.
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inefficient TCR rearrangement and reduced pre-TCR signaling in 
Rag2R229Q/R229Q mice would result in impaired medullary expansion 
and Aire expression. We have also found that the number of nTregs 
was dramatically reduced in the thymi and peripheral tissues of 
the Rag2R229Q/R229Q mice, suggesting that impaired peripheral toler-
ance may also contribute to the development of autoimmunity in 
our murine model.
In contrast to the leakiness observed in the T cell compartment, 
B cell differentiation was more heavily affected in Rag2R229Q/R229Q 
mice, with a predominant block at the pro–B cell stage and a 
dearth of mature B lymphocytes both in the bone marrow and 
in the periphery. These findings largely overlap those reported in 
patients with OS (31).
The observation that the leakiness of the immunological phe-
notype of Rag2R229Q/R229Q mice was more apparent in T than in 
B lymphocytes, while consistent with observations in patients with 
OS, may reflect stronger pressure for peripheral expansion within 
the T lymphocyte lineage.
A remarkable finding of the present study was the variability of 
the phenotypic manifestations observed in Rag2R229Q/R229Q mice, 
with 60% of mice developing skin and hair abnormalities and 4% 
developing severe erythrodermia and weight loss. This variability 
mimicked that observed in humans and may be due to different 
factors, including variability in the genetic background.
The analysis of intracellular cytokine production after stimula-
tion with PMA/ionomycin revealed increased production of IL-2, 
IFN-γ, and TNF-α, indicating Th1 profile production. These find-
ings are in contrast with observations in OS patients. We specu-
late that environmental factors and antigen overload could play 
a role in the induction of increased IL-4 production and thereby 
favor IgE synthesis in patients with OS. Moreover, genetic back-
ground has been shown to influence Th1/Th2 balance and IgE 
serum levels (32). The Rag2R229Q/R229Q mice generated in our labo-
ratory carried the hypomorphic Rag2 mutation on a mixed Sv129 
× C57BL/6 genetic background. In addition, these mice were kept 
under specific pathogen–free conditions. Therefore, we cannot 
exclude a possible effect of antigen encounter on the complexity 
of phenotypic manifestations. Future experiments with pathogen 
exposure and antigen challenge will help clarify this issue. The 
hypothesis that infiltration of target organs by oligoclonal T cells 
in patients with OS could be a result of defective negative selec-
tion of autoreactive T cell clones can now be explored by crossing 
Rag2R229Q/R229Q mice with TCR transgenic mice, followed by expo-
sure to the specific antigen.
In summary, we have shown that introduction of a homozygous 
Rag2 R229Q mutation in mice caused disturbed lymphoid devel-
opment and phenotypic changes that largely recapitulated the 
spectrum of clinical manifestations associated with hypomorphic 
RAG mutations seen in humans with OS. Therefore, we propose 
this mouse model may be a useful tool to gain further insight into 
the pathophysiology of this complex syndrome.
Methods
Construction of Rag2-R229Q/GFP targeting vector. QuikChange XL Site-Direct-
ed mutagenesis kit (Stratagene) was used to introduce nucleotide changes in 
the SalI/AseI Rag2 fragment containing the coding region (GenBank acces-
sion number AC084753). The first nucleotide exchange was GC→AG at posi-
tion 841–842, which led to the R229Q amino acid change. In addition, in 
order to perform an easier identification of the targeted ES clones, we intro-
duced 2 silent mutations at positions 823 (A→G) and 826 (T→A), creating 
a new NheI site. The mutated SalI/AseI fragment was subsequently cloned 
into the SacI site of the Clontech pEGFP-N1 vector and sequenced in order 
to verify that the RAG2 GFP fusion gene was in frame (pRAG2-EGFP-N1 
construct). This step was performed according to the strategy previously 
described by Monroe et al. (18). A 750-bp AseI/KpnI fragment containing 
the 3′ UTR of Rag2 was cloned into the NotI site of the pRAG2-EGFP-N1 
construct (pRAG-EGFP-UTR-N1 construct). The Rag2 coding region fused 
to GFP was subsequently cloned into a pPNT vector containing a floxed neo 
cassette. Finally, a 5′ homology fragment of 3.0 kb (ClaI/SalI) was cloned 
upstream the mutated Rag2-GFP segment, while a 2.2-kb ClaI/BamHI 3′ 
homology fragment was inserted downstream of the neo cassette.
Generation of Rag2R229Q/R229Q mice. Animal experiments protocol has been 
approved by the Ministry of Health and Local authorities (Institutional Ani-
Figure 7
Serum concentration of Igs. Sera from Rag2+/+ and Rag2R229Q/R229Q 
mice were collected and their IgG1, IgG2, IgG3, IgA, and IgM were 
evaluated by Bioplex analysis, while ELISA assay was performed to 
measure IgE production. Bars represent the median for each group. 
P values were determined by Mann-Whitney test.
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mal Care and Use Committee 5/2005, Milan, Italy). The Rag2 targeting vec-
tor was transfected into 129Sv ES cells according to standard electropora-
tion procedures using 40 μg of linearized NotI plasmid, and ES clones were 
selected by G418/gancyclovir resistance. Targeted ES clones were screened 
by PCR, using a 5′ primer located upstream of the targeting vector inser-
tion site and a 3′ primer downstream of the NheI site, and subsequently 
sequenced to verify the presence of nucleotide changes. Positive clones were 
further confirmed by Southern blot analysis using a probe located in the 
3′ region (a 520-bp BamHI/EcoRV fragment) on EcoRV-digested genomic 
DNA. Targeted ES clones were injected in blastocysts, the resulting chime-
ras were bred with C57BL/6 mice, and heterozygous animals were identified 
with the same approach used to identify ES clones. These mice were crossed 
to CMV-Cre transgenic mice in order to achieve neo cassette excision. South-
ern blot analysis performed on EcoRV-digested genomic DNA using the 
previously described probe revealed neo cassette excision: the heterozygous 
floxed mice showed a wild-type band together with a slightly shorter band 
as a result of the introduction of an additional (polylinker-derived) EcoRV 
site during the vector construction. We intercrossed Rag2+/R229Q mice to pro-
duce homozygous knockin Rag2R229Q/R229Q mice.
Histology. Mice were sacrificed at different time points after birth, and 
tissue samples were partially fresh-frozen in cryostat embedding medium 
(Bio-Optica) and partially fixed in 10% neutral-buffered formalin for both 
paraffin embedding and cryoprotection in 30% sucrose/PBS before freez-
ing into cryostat embedding medium. Sections from both paraffin and 
frozen blocks were submitted for histological and immunohistochemical 
evaluation. H&E staining was used to study basic histopathological fea-
tures. Frozen sections were air-dried for 18–24 hours, then fixed in acetone 
and used for immunohistochemistry by an indirect immunoperoxidase 
technique. The following primary antibodies were applied: rat anti-CD3ε 
(clone CT-CD3; Valter Occhiena), rat anti-CD4 (clone GK1.5; Southern 
Biotechnology Associates), rat anti-CD8 (clone CT-CD8a; Valter Occhi-
ena), rat anti-B220 (clone RA3-6B2; Valter Occhiena), and goat anti-CD30 
(clone TNFRSF8; R&D Systems). Immunostains on paraffin sections for 
CD30 and CD3 were performed upon antigen retrieval with microwave 
treatment in 1.0 mM EDTA buffer, pH 8.0, for 15 minutes. Primary anti-
bodies were applied for 2 hours and followed by 30 minutes’ incubation 
in buffer containing the biotinylated specific secondary antibodies (Vec-
tor Laboratories). Immunolabeling was then performed by incubation for 
Figure 8
AIRE expression analysis and cellular infiltration in target organs. (A) 
Amplification of Aire cDNAs obtained from Rag2+/+, Rag2 R229Q/R229Q, 
and Rag2–/– thymic mRNAs. As an internal control, Gapdh was used. 
(B–E) Inflammatory infiltration in the lungs and livers of Rag2+/+ and 
Rag2R229Q/R229Q mice. Compared with the Rag2+/+ mouse (B), histo-
logical analysis of a representative 4-month-old Rag2R229Q/R229Q mouse 
revealed dense peribronchiolar and perivascular inflammatory infiltra-
tion in the lung (C) composed mainly of CD3+ lymphocytes (C, inset). 
Similarly, in contrast to the control mouse (D), dense inflammatory infil-
tration composed of CD3+ T cells was found in liver portal tracts (E and 
inset). Original magnification, ×10 (B–E); ×40 (insets). 
Figure 9
Analysis of nTregs in Rag2R229Q/R229Q mice. (A) Fluorescence-activat-
ed cell sorting analysis of thymus and spleen cells stained with CD25 
and Foxp3 antibodies electronically gated on CD4+ cells. Numbers 
indicate the percentages of total live cells. (B) Histograms show per-
centage of CD25highFoxp3+ cells in thymi, spleens, and lymph nodes 
of Rag2+/+ and Rag2R229Q/R229Q mice. P values were determined by 
unpaired Student’s t test. 
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20 minutes with streptavidin-peroxidase amplification system (BioGenex) 
and revealed using 3-amino-9-ethylcarbazole (Lab Vision). Slides were 
counterstained with hematoxylin. Images were acquired with an Olympus 
DP70 digital camera mounted on an Olympus BX60 microscope, using 
AnalySIS imaging software (version 3.2; Olympus).
Lymphocyte proliferation and intracellular cytokine staining. CD90+ T cells were 
purified from splenocytes of Rag2R229Q/R229Q mice using anti-CD90 MACS 
microbeads (Miltenyi Biotec); resuspended in RPMI 1640 containing 
10% heat-inactivated FCS, 2 mM glutamine and penicillin/streptomycin 
(100 IU/ml), and 10 μM 2-mercaptoethanol; and placed in flat-bottomed 
96-well plates in the presence of surface-bound anti–mouse CD3 mAb 
(0.2, 2, and 20 μg/ml) alone or combined with 100 IU/ml IL-2 (Proleukin 
[aldesleukin]; Chiron) and 2 μg/ml anti-CD28. After 72 hours, cells were 
pulsed for 14–16 hours with 0.037 MBq (1 μCi) per well of [3H]-thymidine 
(Amersham Pharmacia Biotech). Cells were then harvested, and prolifera-
tion (in cpm) was measured in a scintillation counter. For intracellular 
cytokine staining, 1 × 106 cells obtained from lymph nodes were stimu-
lated for 2 hours with 1 mM ionomycin and 10–6 M PMA. After addition of 
5 μg/ml brefeldin A for 2 hours, cells were stained with FITC-conjugated 
CD8 and PerCP-conjugated CD4 antibodies. Cells were fixed in 2% form-
aldehyde and, after washing in permeabilization buffer (PBS containing 
2% FCS and 0.5% saponin), were stained with allophycocyanin-conjugated 
(APC-conjugated) anti–IFN-γ, PE-conjugated anti–IL-4, APC-conjugated 
anti–TNF-α, and APC-conjugated anti–IL-2 antibodies.
Fluorescence-activated cell sorting analysis and antibodies. Single cell suspen-
sions from thymi, bone marrow, spleens, and lymph nodes were prepared 
and stained with specific fluorescent-conjugated antibodies. Thymocytes 
were incubated with the following antibodies: APC- or PerCP-conjugated 
anti-CD4, PE- or CyChrome-conjugated anti-CD8, FITC-conjugated anti-
CD44, PE-conjugated anti-CD25, FITC-conjugated anti-CD69, PE-con-
jugated anti–TCR-γ, and FITC-conjugated anti–TCR-β. Bone marrow, 
spleen, and lymph node cells were stained with PE-conjugated anti-B220, 
biotin-conjugated anti-CD43, PE-conjugated anti-IgM, FITC-conjugated 
anti-IgD, FITC-conjugated anti-CD21, and PE-conjugated anti-CD23. 
Samples stained with byotin-conjugated antibodies underwent an addi-
tional incubation with CyChrome-conjugated streptavidin. PE-conju-
gated anti–CD1d tetramer antibodies were kindly provided by C. Terhorst 
(Harvard Medical School, Boston, Massachusetts, USA). The staining 
with anti-Foxp3 mAbs (FJK-16s; eBioscience) was performed following 
the manufacturer’s instructions. All the antibodies used were from BD. At 
least 100,000 live cells were acquired on a FACSCalibur system (BD) and 
analyzed with FLOWJO software (version 4.5.4; Treestar Inc.).
Serum Ig quantification and specific antibody production. Levels of IgG1, 
IgG2a, IgG2b, IgG3, IgA, and IgM were measured in sera collected from 
Rag2R229Q/R229Q mice by multiplex assay kit (Beadlyte Mouse Immuno-
globulin Isotyping Kit; Upstate). Samples were prepared according to the 
manufacturer’s instructions. The assay was run using Bio-Plex reader (Bio-
Rad). Levels of IgE were determined by ELISA assay (BD Biosciences).
To verify antigen-specific production, anesthetized mice were injected 
subcutaneously into footpads with 100 μg OVA (grade V; Sigma-Aldrich) 
mixed at a 1:1 ratio with CFA (Sigma-Aldrich). OVA-specific IgM, IgG1, 
IgG2a, and IgG2b levels were assessed by ELISA on serum obtained 7 days 
following boost, performed one month after the first immunization.
RNA extraction and RT-PCR. Total RNA was prepared from the thymus 
using SV-total RNA isolation kit (Promega) followed by DNAse digestion 
in order to eliminate any residual DNA. Reverse transcription was per-
formed with SuperScript II according to the manufacturer’s directions 
(Invitrogen). An aliquot (1 μl) of cDNA was used for the PCR reaction (30 
cycles; annealing temperature, 58°C) in PerkinElmer Gene Amp9700 Sys-
tem to assess the expression of Aire with the following primers: forward, 
5′-TGCATAGCATCCTGGACGGCTTCC-3′; reverse, 5′-CCTGGGCT-
GGAGACGCTCTTTGAG-3′. As an internal control, Gapdh transcript 
was amplified with the following oligos: forward, 5′-TGTCAGCAATG-
CATCCTGCA-3′; reverse, 5′-TGGATGCAGGGATGATGTTC-3′.
TCRVβ quantitative immunoscope analysis. cDNAs were obtained from 
CD90+ cells isolated from thymus and spleen using positive selection 
(Miltenyi Biotec). TCRVβ repertoire analysis was performed as previously 
described (33). Briefly, cDNA was amplified with each of the 24 TCRVβ 
family member–specific primers together with a TCRCβ primer and a 
TaqMan Minor Groove Binder (MGB) Probe (Applied Biosystems) for 
TCRCβ. Real-time quantitative PCR was carried out on an ABI 7300 sys-
tem (Applied Biosystems). PCR products were then subjected to runoff 
reactions using a nested fluorescent primer specific for the TCRCβ seg-
ment. The fluorescent products were separated and analyzed on a 373A 
sequencer (Applied Biosystems). The size and intensity of each band 
were analyzed by the quantitative Immunoscope approach (33, 34). The 
Gaussian distribution of the different CDR3 lengths was characteristic 
of normal TCRVβ repertoire.
Statistics. For comparison between groups, an unpaired 2-tailed Stu-
dent’s t test was used. Mann-Whitney test (nonparametric analysis) was 
used to evaluate the significance of Ig differences. A P value less than 0.05 
was considered significant.
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